title: A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus.
abstract: Two different morphogenic processes of retroviral capsid assembly have been observed: the capsid is either assembled at the plasma membrane during the budding process (type C), or preassembled within the cytoplasm (types B and D). We describe here a gag mutant of Mason-Pfizer monkey virus, a type D retrovirus, in which a tryptophan substituted for an arginine in the matrix protein results in efficient assembly of capsids at the plasma membrane through a morphogenic process similar to that of type C retroviruses. We conclude that a type D retrovirus Gag polyprotein contains an additional, dominant signal that prevents immediate transport of precursors from the site of biosynthesis to the plasma membrane. Instead, they are directed to and retained at a cytoplasmic site where a concentration sufficient for self-assembly into capsids occurs. Thus, capsid assembly processes for different retroviruses appear to differ only in the intracellular site to which capsid precursors are directed.
authors.affiliation: Department of Microbiology, University of Alabama, Birmingham 35294.
authors.forename: S S
authors.initials: SS
authors.lastname: Rhee
authors.forename: E
authors.initials: E
authors.lastname: Hunter
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D030121:Betaretrovirus / Q000235:genetics* / Q000254:growth & development; D002213:Capsid / Q000235:genetics; D002460:Cell Line; D002999:Clone Cells; D015683:Gene Products, gag / Q000235:genetics; D006367:HeLa Cells / Q000378:metabolism; D008969:Molecular Sequence Data; D009024:Morphogenesis; D009154:Mutation; D012190:Retroviridae / Q000235:genetics* / Q000254:growth & development; D012689:Sequence Homology, Nucleic Acid; D014162:Transfection; D014763:Viral Matrix Proteins / Q000235:genetics*; D014771:Virion / Q000235:genetics / Q000254:growth & development
chemical_list: D015683:Gene Products, gag; D014763:Viral Matrix Proteins